Home > Insider Trading > Filing (0001415889-24-026944)

Filing Details

Accession Number:: 0001415889-24-026944
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2024-11-15 16:05:16
Reporting Period:: 2024-11-13

Accepted Time:: 2024-11-15 16:05:16
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1831828	Vera Therapeutics Inc.	VERA	Pharmaceutical Preparations (2834)	812744449

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1859453	Marshall Fordyce	C/O Vera Therapeutics, Inc. 2000 Sierra Point Parkway, Suite 1200 Brisbane CA 94005	President And Ceo	No	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Class A Common Stock	Acquisiton	2024-11-13	12,218	$2.90	98,160	No	4	M	Direct
Class A Common Stock	Disposition	2024-11-13	12,218	$49.54	85,942	No	4	S	Direct
Class A Common Stock	Acquisiton	2024-11-13	3,307	$2.90	89,249	No	4	M	Direct
Class A Common Stock	Disposition	2024-11-13	3,307	$50.28	85,942	No	4	S	Direct
Class A Common Stock	Acquisiton	2024-11-13	100	$2.90	86,042	No	4	M	Direct
Class A Common Stock	Disposition	2024-11-13	100	$51.20	85,942	No	4	S	Direct
Class A Common Stock	Acquisiton	2024-11-13	1,565	$2.90	87,507	No	4	M	Direct
Class A Common Stock	Disposition	2024-11-13	1,565	$49.59	85,942	No	4	S	Direct
Class A Common Stock	Acquisiton	2024-11-13	310	$2.90	86,252	No	4	M	Direct
Class A Common Stock	Disposition	2024-11-13	310	$50.35	85,942	No	4	S	Direct
Class A Common Stock	Acquisiton	2024-11-13	1,875	$2.90	87,817	No	4	M	Direct
Class A Common Stock	Disposition	2024-11-13	1,875	$49.57	85,942	No	4	S	Direct
Class A Common Stock	Acquisiton	2024-11-13	1,875	$2.90	87,817	No	4	M	Direct
Class A Common Stock	Disposition	2024-11-13	1,875	$49.52	85,942	No	4	S	Direct
Class A Common Stock	Acquisiton	2024-11-13	1,875	$2.90	87,817	No	4	M	Direct
Class A Common Stock	Disposition	2024-11-13	1,875	$49.50	85,942	No	4	S	Direct
Class A Common Stock	Acquisiton	2024-11-13	7,500	$2.90	93,442	No	4	M	Direct
Class A Common Stock	Disposition	2024-11-13	7,500	$49.00	85,942	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	S	Direct
No	4	M	Direct
No	4	S	Direct
No	4	M	Direct
No	4	S	Direct
No	4	M	Direct
No	4	S	Direct
No	4	M	Direct
No	4	S	Direct
No	4	M	Direct
No	4	S	Direct
No	4	M	Direct
No	4	S	Direct
No	4	M	Direct
No	4	S	Direct
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Class A Common Stock	Stock Option (Right to Buy)	Disposition	2024-11-13	15,625	$0.00	15,625	$2.90
Class A Common Stock	Stock Option (Right to Buy)	Disposition	2024-11-13	1,875	$0.00	1,875	$2.90
Class A Common Stock	Stock Option (Right to Buy)	Disposition	2024-11-13	1,875	$0.00	1,875	$2.90
Class A Common Stock	Stock Option (Right to Buy)	Disposition	2024-11-13	1,875	$0.00	1,875	$2.90
Class A Common Stock	Stock Option (Right to Buy)	Disposition	2024-11-13	1,875	$0.00	1,875	$2.90
Class A Common Stock	Stock Option (Right to Buy)	Disposition	2024-11-13	7,500	$0.00	7,500	$2.90

Remaning Holdings	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
753,587	2030-12-15	No	4	M	Direct
751,712	2030-12-15	No	4	M	Direct
749,837	2030-12-15	No	4	M	Direct
747,962	2030-12-15	No	4	M	Direct
746,087	2030-12-15	No	4	M	Direct
738,587	2030-12-15	No	4	M	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Class A Common Stock	222,030	Indirect	By GRAT

Footnotes

Excludes 222,030 shares previously owned directly, which on November 7, 2024, were contributed to a grantor retained annuity trust, in which the Reporting Person is the sole grantee and annuitant.
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on April 23, 2024.
The price reported is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $49.02 to $50.01, inclusive. The Reporting Person will provide upon request to the staff of the Securities and Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares sold at each separate price.
The price reported is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $50.02 to $50.67, inclusive. The Reporting Person will provide upon request to the staff of the Securities and Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares sold at each separate price.
The price reported is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $49.05 to $50.03, inclusive. The Reporting Person will provide upon request to the staff of the Securities and Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares sold at each separate price.
The price reported is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $50.13 to $50.78, inclusive. The Reporting Person will provide upon request to the staff of the Securities and Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares sold at each separate price.
The price reported is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $49.00 to $49.88, inclusive. The Reporting Person will provide upon request to the staff of the Securities and Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares sold at each separate price.
1/4 of the shares subject to the option vested on December 16, 2021, and 1/48 of the shares vest monthly thereafter.